[多细胞血病患者骨髓纤维形成的可能危险因素]
De-Hao Wang1,2, Pei Zhao1,2, Zi-Qing Wang1,2
1Graduate School of Beijing University of Chinese Medicine, Beijing 100029, China.
Zhongguo shi yan xue ye xue za zhi
|December 9, 2023
概括
周围血液中乙氨基的增加和低密度脂蛋白的减少是多细胞血真 (PV) 患者骨髓纤维化的主要危险因素. 识别这些因素有助于预测和管理光伏增长.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 病理学 病理学 病理学
背景情况:
- 多细胞血症 (PV) 是一种骨髓增殖性新生体,其特点是红细胞的过度生产.
- 骨髓纤维化或骨髓纤维化是PV的常见并发症,可能导致显著的发病率.
- 了解骨髓纤维形成的风险因素对于预测疾病进展和患者的结果至关重要.
研究的目的:
- 为了研究多细胞血病真 (PV) 患者的生物特征,骨髓纤维化.
- 为了确定与PV患者骨髓纤维化发展相关的风险因素.
- 为预测PV中的骨髓纤维形成提供见解.
主要方法:
- 40名PV患者的队列根据骨髓纤维化被分为增生和非增殖组.
- 临床特征,血细胞计数,生物化学,骨髓分析和凝血功能在各组之间进行了比较.
- 使用多变量回归分析来确定骨髓纤维化的独立风险因素.
主要成果:
- 患有增生症的PV患者表现出显著更高的JAK2突变率,乙素细胞数量/百分比和粒细胞/红细胞比率.
- 甘油三和低密度脂蛋白水平在增生组明显较低.
- 周围血液中乙氨基酸细胞数量≥2%和低密度脂蛋白水平≤2 mmol/L被确定为骨髓纤维化独立的危险因素.
结论:
- 周围血液中异osinophil 的比例增加是 PV 中骨髓纤维组织增生的一个重要危险因素.
- 降低低密度脂蛋白水平也与PV患者患骨髓纤维化风险增加有关.
- 这些发现突出了预测多细胞真血症中髓状纤维形成的潜在生物标志物.
相关概念视频
Disorders of Erythrocytes
948
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
948
Factors Affecting Erythropoiesis
3.3K
The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
3.3K
Role of Hematopoietic Growth Factors
1.4K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.4K
Bone Marrow Sampling and Transplants
333
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
333
Erythropoiesis
4.3K
Red blood cells (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia,...
4.3K
Disorders of Hemostasis
922
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
922


